15 min

Regulatory Considerations for Biosimilars Development in the U.S‪.‬ Advancing Revolutionary Therapies

    • Arts

The development of biosimilar products in the US has been progressing since the regulatory pathway was established as part of the Affordable Care Act. Listen as members of Veristat’s Regulatory team delve into the analytical and clinical science of biosimilars and their regulatory pathway.  

The development of biosimilar products in the US has been progressing since the regulatory pathway was established as part of the Affordable Care Act. Listen as members of Veristat’s Regulatory team delve into the analytical and clinical science of biosimilars and their regulatory pathway.  

15 min

Top Podcasts In Arts

The Bookshelf with Ryan Tubridy
Ryan Tubridy
I Think You Should Read
Rachel O'Neill and Áine O'Connell
Style-ish
Shameless Media
Dish
S:E Creative Studio
Table Manners with Jessie and Lennie Ware
Jessie Ware
Changing Times - The Allenwood Conversations
Mary McAleese & Mary Kennedy - Dundara Television and Media